US Patent 11311521 Solid dispersion forms of rifaximin
Patent 11311521 was granted and assigned to Salix Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11311521 Solid dispersion forms of rifaximin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
